The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
enzon pharmaceuticals | 105 |
santaris pharma | 34 |
enzon | 7 |
ehnzon farmas'jutikalz | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
lna antagonists targeting the androgen receptor | 31 | 2007 |
potent lna oligonucleotides for the inhibition of hif-1a expression | 25 | 2004 |
enzymatic anticancer therapy | 24 | 2007 |
rna antagonist compounds for the modulation of beta-catenin | 23 | 2007 |
stable recombinant adenosine deaminase | 23 | 2007 |
oligomeric compounds for the modulation of hif-1alpha expression | 20 | 2002 |
recombinant host for producing l-asparaginase ii | 18 | 2006 |
rna antagonist compounds for the modulation of pik3ca expression | 17 | 2007 |
multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast… 🛈 | 17 | 2006 |
polymeric conjugates of c1-inhibitors | 15 | 2012 |